Clinical trial
Randomized Controlled Trial of Hemostatic Powder Versus Optimal Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions
NCT02820077 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Hemostatic Powder Versus Optimal Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions
- Lead sponsor
- Instituto do Cancer do Estado de São Paulo
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 6, 2016
- Completion date
- August 27, 2020
- Enrollment
- 62 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.